Pharmocann Global Ltd. Logo

Pharmocann Global Ltd.

Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.

PMCN-M | TA

Overview

Corporate Details

ISIN(s):
IL0010968902
LEI:
Country:
Israel
Address:
Horesh Haalonim 1, 3009500 Ramat Yishai
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Blue Wave Water Capital Ltd., formerly known as Pharmocann Global Ltd., is a publicly traded company with over 14 years of experience in the medical cannabis industry. The company has historically specialized in the development and production of pharma-grade medical cannabis products, including oils, ointments, tablets, and inhalers, as well as hemp-based cosmetics and seed oils. A recent corporate decision resulted in a name change and a strategic shift, with the company now operating as Blue Wave Water Capital Ltd.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 19:38
Regulatory News Service
The sector classification of BLUE WAVE WATER CAPITAL will be changed, as of Au…
English 99.3 KB
2025-02-17 18:43
Regulatory News Service
Changes in the company's name and security, effective as of February 19, 2025
Hebrew (modern) 118.3 KB
2023-10-03 16:36
Regulatory News Service
Excellence will cease to operate as a market maker in the company's shares as o…
Hebrew (modern) 118.8 KB
2020-08-23 11:39
Investor Presentation
Investors Presentation - August 2020
English 20.2 MB
2020-08-23 11:39
Registration Form
Investors Presentation - August 2020
Russian 42.3 KB

Automate Your Workflow. Get a real-time feed of all Pharmocann Global Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmocann Global Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmocann Global Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea 291650
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden ACE
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan 4886
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan 4503

Talk to a Data Expert

Have a question? We'll get back to you promptly.